Zovighian Bernard J 4
4 · Edwards Lifesciences Corp · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Edwards Lifesciences (EW) CEO Bernard J. Zovighian Sells 523 Shares
What Happened Bernard J. Zovighian, CEO and Director of Edwards Lifesciences (EW), reported a sale of 523 shares on June 17, 2026. The shares were disposed at $87.92 each, for a total transaction value of $45,982. This was a sale (not a purchase or option exercise) and is typically considered a routine disposition by an insider.
Key Details
- Transaction date and price: 2026-06-17, 523 shares sold at $87.92 per share.
- Total value: $45,982.
- Shares owned after transaction: Not specified on this Form 4 (the filing only reports the change).
- Footnote: Transaction executed pursuant to a Rule 10b5-1 trading plan adopted December 12, 2025.
- Timeliness: Reported on Form 4 with the same transaction date—no late filing indicated.
Context A 10b5-1 trading plan means the sale was arranged under a pre-established plan and may not reflect the insider’s current view of the company. Sales like this are common for liquidity or diversification and, by themselves, do not necessarily signal material information about company prospects.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-06-17$87.92/sh−523$45,982→ 11,516.551 total(indirect: By Trust)
- 99,164.65
Common Stock
- 3,733.56(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.